-
Financial Screenings for People with Cancer
Cancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
-
Let Me Tell You a Story About the Power of Medical Research
Ten-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
-
Aggressive Approach to Very Advanced Cancer Does Not Extend Survival
Study shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose
-
The Affordable Care Act’s Impact on Access to Cancer Care
A study at the AACR Cancer Health Disparities Conference found more people got quality cancer care after the ACA went into effect.
by Cancer Research Catalyst
-
Understanding the Federal Rule on Breast Tissue Density Reports
Screening mammography reports will include breast density and an explanation in common language.
by Sandra Gordon
-
Making Cancer a Family Affair
Instead of hiding details of her metastatic breast cancer diagnosis from her children, Michelle Audoin opened the door for clear expectations and frank conversations.
by Michelle Audoin
-
Advocacy After Loss
Following her son’s death from peripheral T-cell lymphoma, Sandy McHugh keeps his memory alive through Jake’s Dragon Foundation.
by Thomas Celona
-
Telehealth Palliative Care Provides the Same Benefits as In-person Care
Researchers hope effective telehealth will increase access to palliative care for more cancer patients.
by Taneia Surles
-
Sensorimotor Training Helps Prevent Chemotherapy-induced Peripheral Neuropathy
The specialized balance training exercise can help keep the nervous system healthy during chemotherapy by giving it a workout.
by Sandra Gordon
-
What Is Liquid Biopsy?
Blood tests, often called liquid biopsy, could be key to early cancer detection and monitoring response to treatment.
by Cancer Research Catalyst
Cancer Talk
Treating Smoldering Multiple Myeloma
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona